Skip to content
  • 6,813 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started
Menu

Award notice

Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)

75A50124C00046

Office of Assistant Secretary for Preparedness and Response, Barda - Aspr / Daappo / Barda DCMA. Research and Development in Biotechnology (except Nanobiotechnology).

18 open like this View on SAM.gov Markdown

Awarded

Cerus Corporation

$248,591,407.65 on the award notice, September 23, 2024, contract 75A50124C00046

Get the next one like this from Office of Assistant Secretary for Preparedness and Response by email, the day it is posted.Find my opportunities

This one was awarded in 2024

18 like it are open now in research and development in biotechnology (except nanobiotechnology)

All 18 open in research and development in biotechnology (except nanobiotechnology)

Description

As published on SAM.gov.

License pathogen reduction technology (PRT) for red blood cell (RBC) components to reduce the risk of transfusion-transmitted infection (TTI) by recognized emerging, epidemic, and endemic pathogens that is capable of treating over 10 million RBC components per year.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Cerus Corporation
UEI
KJJQRRLY2FL5
CAGE
1PVJ6
Vendor location
Concord, CA
Contract
75A50124C00046, definitive contract
Obligated
$65,358,563.95, potential $209,038,158
Actions
4 between September 20, 2024 and July 21, 2026
Competition
Full and Open Competition, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
License Pathogen Reduction Technology (Prt) for Red Blood Cell (Rbc) Components to Reduce the Risk of Transfusion-Transmitted Infection (Tti) by Recognized, Emerging, Epidemic, and Endemic Pathogens That Is Capable of Treating Over 10 Million RBC Com
Match
award number 75A50124C00046 equals the contract number; same awarding office 75A501 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. October 7, 2024

    Award notice, originally solicitation

    Awarded to CERUS CORPORATION Concord for $248,591,408. SAM.gov, notice dd5785c70ab7460c970270efb9eef18c

Points of contact